DEXTROAMPHETAMINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Dextroamphetamine Sulfate patents expire, and what generic alternatives are available?
Dextroamphetamine Sulfate is a drug marketed by Able, Actavis Elizabeth, Dr Reddys Labs Sa, Nesher Pharms, Norvium Bioscience, Specgx Llc, Strides Pharma, Prasco, Tris Pharma Inc, Ani Pharms, Aurolife Pharma Llc, Avanthi Inc, Azurity, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vitarine, and Winder Labs Llc. and is included in thirty-three NDAs.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dextroamphetamine Sulfate
A generic version of DEXTROAMPHETAMINE SULFATE was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXTROAMPHETAMINE SULFATE?
- What are the global sales for DEXTROAMPHETAMINE SULFATE?
- What is Average Wholesale Price for DEXTROAMPHETAMINE SULFATE?
Summary for DEXTROAMPHETAMINE SULFATE
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 33 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,108 |
| Drug Prices: | Drug price information for DEXTROAMPHETAMINE SULFATE |
| What excipients (inactive ingredients) are in DEXTROAMPHETAMINE SULFATE? | DEXTROAMPHETAMINE SULFATE excipients list |
| DailyMed Link: | DEXTROAMPHETAMINE SULFATE at DailyMed |
Recent Clinical Trials for DEXTROAMPHETAMINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vallon Pharmaceuticals, Inc. | Phase 1 |
| Medical University of Vienna | N/A |
| Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
Pharmacology for DEXTROAMPHETAMINE SULFATE
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for DEXTROAMPHETAMINE SULFATE
US Patents and Regulatory Information for DEXTROAMPHETAMINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090652-001 | Mar 7, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-001 | Oct 25, 2011 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nesher Pharms | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 206588-001 | Mar 28, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040299-001 | May 13, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 083903-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nesher Pharms | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040367-001 | Oct 31, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
